<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01265758</url>
  </required_header>
  <id_info>
    <org_study_id>UDAPOIG.01.03.01-00-068/09-00A</org_study_id>
    <nct_id>NCT01265758</nct_id>
  </id_info>
  <brief_title>Telemetric Arrhythmia Diagnosis in Adults</brief_title>
  <acronym>TELEMARC1</acronym>
  <official_title>OPTIMIZING DIAGNOSTICS AND THERAPY OF ARRHYTHMIA AND SYNCOPE EVENTS USING INTELLIGENT TELEMETRIC SOLUTIONS - Evaluation of Arrhythmia Diagnostics in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Cardiology, Warsaw, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Cardiology, Warsaw, Poland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess efficacy of prolonged Full Disclosure
      electrocardiogram (ECG) monitoring and signal analysis using advanced telemetric technology
      in comparison with a standard Holter ECG recording and an Event Holter recording to diagnose
      cardiac arrhythmia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Irregular and/or rapid beating of the heart called heart palpitations can occur in
      individuals without heart disease and the reasons for their palpitations are unknown.
      Together with heart palpitations silent arrhythmia may be present that could lead to serious
      complications (eg. stroke). In others, palpitations result from heart rhythm disturbances,
      sometimes life threatening. Standard diagnostic methods such as 24 hours Holter ECG
      monitoring or Event Holter do not guarantee early diagnosis of the arrhythmia. Prolonged
      heart rhythm recording and analysis using an automatic full disclosure telemetric device
      increase probability of arrhythmia diagnosis and early administration of applicable
      treatment. Study patients will be diagnosed using standard Holter ECG monitoring and 14 days
      telemetric full disclosure ECG monitoring. The full disclosure signal will be subsequently
      analyzed in the Event Monitoring mode by an independent consultant. Efficacy of Telemetric
      Monitoring in diagnosis of cardiac arrhythmia will be assessed in comparison with the
      standard Holter monitoring and Event Monitoring.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recording of symptomatic or life threatening arrhythmia event</measure>
    <time_frame>14 days</time_frame>
    <description>ECG monitoring is conducted until occurrence of symptomatic arrhythmia or life threatening arrhythmia but not longer than 14 days. Patients in the control group will have standard ECG Holter monitoring repeated 3 times unless arrhythmia is diagnosed earlier.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life questionnaire and European Heart Rhythm Association (EHRA) scale assessment against evidence of cardiac arrhythmia occurrence.</measure>
    <time_frame>14 days</time_frame>
    <description>Verification of patient self assessment based on the Quality of Life questionnaire and European Heart Rhythm Association (EHRA) scale against evidence of cardiac arrhythmia occurrence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Silent (asymptomatic) arrhythmia events incidence detection assessment</measure>
    <time_frame>14 days</time_frame>
    <description>Evaluation of silent (asymptomatic) arrhythmia events incidence which potentially could cause serious complications
Atrial fibrillation
Atrial flutter
Atrial Tachycardia
Ventricular tachycardia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of stroke and bleeding risk factors incidence</measure>
    <time_frame>14 days</time_frame>
    <description>Evaluation of stroke and bleeding risk factors incidence based on scores proposed in the European Society of Cardiology (ESC) guidelines: CHADS2VASC2 and HAS-BLED.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Arrhythmia</condition>
  <arm_group>
    <arm_group_label>Telemetric ECG monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Telemetric 14-days Full Disclosure ECG recording.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard 24-hours Holter ECG recording</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard 24-hours Holter ECG recording repeated 3 times unless arrhythmia is diagnosed earlier.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prolonged telemetric Full Disclosure ECG recording.</intervention_name>
    <description>Continuous Full Disclosure Telemetric ECG monitoring lasting 14 days</description>
    <arm_group_label>Telemetric ECG monitoring</arm_group_label>
    <arm_group_label>Standard 24-hours Holter ECG recording</arm_group_label>
    <other_name>Medicalgorithmics, PocketECG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age - between 18 and 80 years old

          -  History of symptoms potentially caused by arrhythmia

          -  Symptoms occuring at least monthly

          -  Patient informed consent

          -  Declarative and feasible compliance (patient understands basic instructions regarding
             device use)

        Exclusion Criteria:

          -  Evidence of previously recorded arrhythmia

          -  Inability to comply with the study protocol

          -  Lack of patient cooperation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lukasz J Szumowski, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Cardiology, Warsaw, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lukasz Szumowski, MD, PhD</last_name>
    <phone>+48501152728</phone>
    <email>lszumowski@ikard.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zbigniew Jedynak, MD, PhD</last_name>
    <phone>+48603786780</phone>
    <email>zjedynak@ikard.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Medical University of Gda≈Ñsk</name>
      <address>
        <city>Gdansk</city>
        <zip>80-210</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janusz Siebert, Prof. MD PhD</last_name>
      <email>jsiebert@amg.gda.pl</email>
    </contact>
    <investigator>
      <last_name>Janusz Siebert, Prof. MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lukasz Szumowski, Prof,</last_name>
      <phone>+48 22 501152728</phone>
      <email>lszumowski@ikard.pl</email>
    </contact>
    <investigator>
      <last_name>Lukasz Szumowski, Prof. MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2010</study_first_submitted>
  <study_first_submitted_qc>December 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2010</study_first_posted>
  <last_update_submitted>February 18, 2013</last_update_submitted>
  <last_update_submitted_qc>February 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2013</last_update_posted>
  <responsible_party>
    <name_title>Prof Lukasz Szumowski</name_title>
    <organization>Institute of Cardiology, Warsaw Poland</organization>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Cardiac arrhythmia</keyword>
  <keyword>ECG</keyword>
  <keyword>Telemonitoring</keyword>
  <keyword>Telemetry</keyword>
  <keyword>Holter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

